High Potency APIs (HPAPIs) Strategic Research Report 2024: Global Market to Reach $46.9 Billion by 2030, Driven by Expansion of Oncology, Hormonal, and Endocrine Therapies
October 10, 2024 11:02 ET
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "High Potency APIs (HPAPIs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for High...
Asia-Pacific CDMO Market Share Analysis, Industry Trends & Growth Forecasts 2024-2029: Demand For Injectable Dose Formulation is Rising in the Market
September 23, 2024 05:47 ET
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)" report has been added to ...
Active Pharmaceutical Ingredients (API) Business Research Report 2024: Market to Reach $358.5 Billion by 2030 - North America Dominates, China Continues to Remain a Major Hub
August 30, 2024 07:22 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients (API) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Asia-Pacific Highly Potent API Industry Research 2023-2033: Containment Technology Advances, Increasing Investment for Manufacturing Units, Pharma Companies Outsourcing HPAPIs Production to CDMOs
July 22, 2024 06:16 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Highly Potent API Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The...
Highly Potent Active Pharmaceutical Ingredients (HPAPIs) Market Report 2024-2034
July 11, 2024 10:42 ET
|
Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "Highly Potent Active Pharmaceutical Ingredients (HPAPIs) Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue...
Europe Highly Potent API Market Analysis 2023-2033 with Almac, Axplora, BASF, CordenPharma, Helsinn Healthcare, ICROM, Lonza, Merck, & Sterling Pharma Solutions Dominating the $16 Billion Industry
July 01, 2024 05:29 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Europe Highly Potent API Market - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Europe highly...
Global High Potency API Contract Manufacturing Market Expects Growth with a CAGR of 8.42% Through 2028
April 02, 2024 12:58 ET
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "High Potency API (HPAPI) Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been...
Global Pharmaceutical CDMO Market to Soar with Projected Growth of 6.74% CAGR from 2024 to 2029
April 01, 2024 17:21 ET
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development and Manufacturing Organization (CDMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts...
Global Veterinary API Market Poised for Growth, Expected to Reach USD 13.47 Billion by 2030
April 01, 2024 04:39 ET
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share & Trends Analysis Report by Animal Type (Production,...
Global Highly Potent API (Active Pharmaceutical Ingredient) Industry Research 2023-2033: Growing Emphasis on Personalized Medicine & Increasing Opportunities for Pharma Companies in Developing Markets
March 29, 2024 05:02 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and...